Univest
Univest
  • Markets

Anthem Biosciences (ANTHEM) Share Price Rises 2.38% to Rs 935.95

  • September 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Anthem Biosciences Share Price
Anthem Biosciences Ltd. (ANTHEM) share price rose to Rs 935.95 today, up 2.38% from the previous close. Market cap was Rs 52,079.73 crore.

Anthem Biosciences Share Price is trading higher today, with the stock at Rs 935.95 against the previous close of Rs 914.15. The day move of Rs 21.80 translates into a 2.38% share price rise, while the company’s market capitalisation stands at Rs 52,079.73 Cr. In early trade, the stock opened at Rs 915.80, moved between Rs 915.75 and Rs 935.95, and is currently at the day’s high. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Anthem Biosciences Share Price Today, the key question is not just the move itself but how the valuation and sector benchmarks frame it. This Anthem Biosciences Stock News update therefore focuses on today’s price action, fundamentals and Healthcare context.

Table of Contents

Toggle
  • Anthem Biosciences Share Price Today: Price Action Analysis
  • Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Anthem Biosciences
  • About Anthem Biosciences
  • Frequently Asked Questions
    • Why is Anthem Biosciences Share Price rising today?
    • What is Anthem Biosciences Share Price today?
    • How much did Anthem Biosciences Share Price move today?
    • What is the market capitalisation of Anthem Biosciences?
    • Is Anthem Biosciences Share Price expensive on valuation?
    • How does Anthem Biosciences compare with Healthcare peers?
    • What do EPS and book value mean for Anthem Biosciences Share Price?
    • What does the dividend yield show for Anthem Biosciences?
  • Track Anthem Biosciences Share Price on Univest

Anthem Biosciences Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 935.95
Previous Close Rs 914.15
Today's Move Rs 21.8 (+2.38%)
Open Rs 915.8
High Rs 935.95
Low Rs 915.75
Market Capitalisation Rs 52,079.73 crore
Market Cap Category Large Cap

Anthem Biosciences Ltd. (ANTHEM) rose to Rs 935.95 from the previous close of Rs 914.15, a move of Rs 21.8 or 2.38%. The stock opened at Rs 915.8, reached a high of Rs 935.95, recorded a low of Rs 915.75.

Anthem Biosciences Share Price is higher by Rs 21.80 and is trading at Rs 935.95, or 2.38% above the previous close of Rs 914.15. The move began above the previous close at Rs 915.80 and stayed within a narrow intraday band of Rs 915.75 to Rs 935.95. That places the stock at its day high at the time of writing. For Anthem Biosciences Share Price Today, the clean takeaway is simple: the stock is rising today with a modest gap between the open and the high, and the latest price action remains tightly contained in early trade.

The movement is relevant because it keeps Anthem Biosciences Share Price in focus among Stocks in News and Market Movers without requiring a stated trigger. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers following Anthem Biosciences Share Price Live, the next checkpoint is whether the stock sustains above the opening band or reverts toward the previous close. That is the most important Price Action detail available right now before moving to Anthem Biosciences Fundamental Analysis.

Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 52,079.73 crore
P/E Ratio 83.92x
P/B Ratio 15.7x
ROE 21.98%
ROCE 29.62%
EPS Rs 10.89
Book Value Per Share Rs 58.21
Dividend Yield 0.22%

Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 83.92x, P/B 15.7x, ROE 21.98%, ROCE 29.62%. Read together, these ratios describe the company’s position rather than a recommendation.

Anthem Biosciences Ltd. has a market capitalisation of Rs 52,079.73 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 83.92x, P/B at 15.7x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.89, book value per share of Rs 58.21, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.6x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 83.92x
Benchmark Median P/E 30.6x
Benchmark Average P/E 59.27x
Benchmark P/E Range 2.71x to 1,378.1x
Company P/B Ratio 15.7x
Benchmark Median P/B 2.8x
Company ROE 21.98%
Benchmark Median ROE 11.23%
Company ROCE 29.62%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 52,079.73 crore
Benchmark Median Market Cap Rs 789.58 crore

Anthem Biosciences Ltd. (ANTHEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 83.92x, which is above the benchmark median of 30.6x, a difference of +174.25%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.23%, a difference of +95.73%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.1%, a difference of +126.11%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,48,687.64 40.96 5.03 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,95,080.27 87.38 16.33 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,677.43 83.06 9.6 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,26,433.06 93.64 20.7 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,19,969.79 28.52 4.29 19.69 21.39

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 83.92x compared with the displayed peer median of 83.06x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 21.98% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 52,079.73 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Anthem Biosciences

  • Anthem Biosciences Share Price is rising today, with the stock at Rs 935.95 and up 2.38% from the previous close.
  • The share price rise keeps Anthem Biosciences Stock News in focus even though no company-specific catalyst is established.
  • Valuation remains elevated, with P/E at 83.92 and P/B at 15.7, so Anthem Biosciences Fundamental Analysis stays important.
  • ROE of 21.98% and ROCE of 29.62% give the stock a strong return backdrop within Healthcare.
  • The company’s market capitalisation of Rs 52,079.73 Cr makes it relevant in Stocks Rising Today screens and broader Market News coverage.

About Anthem Biosciences

Anthem Biosciences Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company works in a business that is typically evaluated on execution, return ratios, pricing power and the quality of earnings support. For readers tracking Anthem Biosciences Share Price, the most visible business context today is the company’s premium valuation and its strong return metrics. The stock’s scale, reflected in market capitalisation, keeps it relevant within the broader listed healthcare universe.

In a practical Company Overview, Anthem Biosciences is best understood through the numbers that accompany its market trade: P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Those metrics help frame Anthem Biosciences Share Price Today without relying on unsupported narrative. The company’s place within the Pharmaceuticals & Drugs industry means investors will usually compare it with sector peers, same-industry benchmarks and the broader Healthcare set when reviewing Anthem Biosciences Stock Analysis.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Anthem Biosciences Share Price rising today?

Ans. Anthem Biosciences Share Price is higher today at Rs 935.95, up 2.38% from the previous close. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.

What is Anthem Biosciences Share Price today?

Ans. Anthem Biosciences Share Price is trading at Rs 935.95. The stock is Rs 21.80 above the previous close of Rs 914.15 and has been moving within a narrow intraday range in early trade.

How much did Anthem Biosciences Share Price move today?

Ans. Anthem Biosciences Share Price has gained Rs 21.80, which equals 2.38% for the day. The stock opened at Rs 915.80 and reached a day high of Rs 935.95 in early trade.

What is the market capitalisation of Anthem Biosciences?

Ans. Anthem Biosciences has a market capitalisation of Rs 52,079.73 Cr. That places Anthem Biosciences Share Price in a sizeable listed Healthcare company, though market cap only indicates scale, not valuation quality.

Is Anthem Biosciences Share Price expensive on valuation?

Ans. Anthem Biosciences Share Price trades on a P/E of 83.92 and a P/B of 15.7. Both are above the same-industry median and average, so the valuation is clearly premium versus the benchmark set.

How does Anthem Biosciences compare with Healthcare peers?

Ans. Anthem Biosciences Share Price sits below several larger peers by market cap, but its ROCE of 29.62% is higher than the listed comparison companies. Its P/E is also above many sector peers.

What do EPS and book value mean for Anthem Biosciences Share Price?

Ans. Anthem Biosciences reports EPS of 10.89 and book value of Rs 58.21. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

What does the dividend yield show for Anthem Biosciences?

Ans. Anthem Biosciences has a dividend yield of 0.22%. For Anthem Biosciences Share Price, that is a low payout marker relative to the current price and should be read alongside valuation and return ratios.

Track Anthem Biosciences Share Price on Univest

Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Anthem Biosciences Share Price can be tracked on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels and company insights. If you want a single place to follow Anthem Biosciences Share Price Today, Univest keeps the essential market and fundamental context together.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply